Comparison of malaria treatment outcome of generic and innovator ’s anti-malarial drugs containing artemether–lumefantrine combination in the management of uncomplicated malaria amongst Tanzanian children

In 2006, artemether –lumefantrine (ALU), specifically Coartem® (Novartis Pharma AG, Basel Switzerland), was approved as the first-line drug for treatment of uncomplicated malaria in Tanzania. Due to poor availabil...

Source: Malaria Journal - April 11, 2019 Category: Infectious Diseases Authors: Manase Kilonzi, Omary Minzi, Ritah Mutagonda, Philip Sasi, Appolinary Kamuhabwa and Eleni Aklillu Tags: Research Source Type: research